Angina pectoris severity among coronary heart disease patients is associated with subsequent cognitive impairment

Alzheimer Disease and Associated Disorders

Volumn 29, Issue 1, 2015, Pages 6-11

  Weinstein, Galit ^a,b   Goldbourt, Uri ^b   Tanne, David ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

angina pectoris; cognitive performance; coronary heart disease

Indexed keywords

ADULT; ANGINA PECTORIS; ARTERIAL WALL THICKNESS; ARTICLE; ATTENTION; CAROTID ATHEROSCLEROSIS; COGNITION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEMORY; PRIORITY JOURNAL; AGED; CLINICAL TRIAL; COGNITION DISORDERS; COMPLICATION; CORONARY DISEASE; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AGED; ANGINA PECTORIS; COGNITION DISORDERS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84924249276     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000038     Document Type: Article

References (36)

1. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med. 2002;136:341-348.
2. von Strauss E, Viitanen M, De Ronchi D, et al. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol. 1999;56:587-592.
3. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672-2713.
4. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154.
5. Aronson MK, Ooi WL, Morgenstern H, et al. Women, myocardial infarction, and dementia in the very old. Neurology. 1990;40:1102-1106.
6. Beeri MS, Rapp M, Silverman JM, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology. 2006;66:1399-1404.
7. Muller M, Grobbee DE, Aleman A, et al. Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis. 2007;190:143-149.
8. Singh-Manoux A, Britton AR, Marmot M. Vascular disease and cognitive function: evidence from the Whitehall II Study. J Am Geriatr Soc. 2003;51:1445-1450.
9. Singh-Manoux A, Sabia S, Lajnef M, et al. History of coronary heart disease and cognitive performance in midlife: the Whitehall II study. Eur Heart J. 2008;29:2100-2107.
10. Bursi F, RoccaWA, Killian JM, et al. Heart disease and dementia: a population-based study. Am J Epidemiol. 2006;163:135-141.
11. PetrovitchH,WhiteL, Masaki KH, et al. Influence of myocardial infarction, coronary artery bypass surgery, and stroke on cognitive impairment in late life. Am J Cardiol. 1998;81:1017-1021.
12. Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54:522-523.
13. Hemingway H, Fitzpatrick NK, Gnani S, et al. Prospective validity of measuring angina severity with Canadian Cardiovascular Society class: the ACRE study. Can J Cardiol. 2004;20:305-309.
14. Tanne D, Shotan A, Goldbourt U, et al. Severity of angina pectoris and risk of ischemic stroke. Stroke. 2002;33:245-250.
15. The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation. 2000;102:21-27.
16. Dwolatzky T, Whitehead V, Doniger GM, et al. Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatr. 2003;3:4.
17. Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association; 1994.
18. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54: 541-553.
19. Muller M, Voges M, Piepgras U, et al. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus. Stroke. 1995;26:96-100.
20. Gresham GA, Howard AN. Atherosclerosis and coronary heart-disease. Lancet. 1960;2:527.
21. Wendell CR, Waldstein SR, Ferrucci L, et al. Carotid atherosclerosis and prospective risk of dementia. Stroke. 2012;43:3319-3324.
22. Suemoto CK, Nitrini R, Grinberg LT, et al. Atherosclerosis and dementia: a cross-sectional study with pathological analysis of the carotid arteries. Stroke. 2011;42: 3614-3615.
23. RJ OB. Vascular dementia: atherosclerosis, cognition and Alzheimer's disease. Curr Alzheimer Res. 2011;8:341-344.
24. Jashari F, Ibrahimi P, Nicoll R, et al. Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis. 2013;227:193-200.
25. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47:C7-12.
26. Davies MJ. The pathophysiology of acute coronary syndromes. Heart. 2000;83:361-366.
27. Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J. 2004;25:1077-1082.
28. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
29. Au R, Massaro JM, Wolf PA, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol. 2006; 63:246-250.
30. Roman GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1: 426-436.
31. Yarchoan M, Xie SX, Kling MA, et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain. 2012;135:3749-3756.
32. Ivan CS, Seshadri S, Beiser A, et al. Dementia after stroke: the Framingham Study. Stroke. 2004;35:1264-1268.
33. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009; 8:1006-1018.
34. Savva GM, Stephan BC. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke. 2010;41:e41-e46.
35. Elias MF, Beiser A, Wolf PA, et al. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol. 2000;57:808-813.
36. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.